Related Experiment Videos

Pneumococci producing beta hemolysis on agar

Insights

Certain pneumococci strains produce a novel beta hemolysin active against horse and sheep red blood cells. This substance requires specific anaerobic and aerobic conditions for activation and appears distinct from previously identified pneumococcal hemolysins.

Area of Science:

  • Microbiology
  • Bacteriology
  • Hemolysis

Background:

  • Streptococcus pneumoniae (pneumococci) are significant human pathogens.
  • Hemolysins are virulence factors produced by various bacteria, including pneumococci.
  • Understanding bacterial hemolysins is crucial for elucidating pathogenicity and developing diagnostics.

Purpose of the Study:

  • To investigate the hemolytic activity of pneumococcal strains on different blood-agar media.
  • To characterize the conditions required for the production and activation of a novel hemolytic substance.
  • To determine if serological type correlates with hemolytic activity.

Main Methods:

  • Culturing fifty-six pneumococcal strains on blood-agar plates.
  • Incubating cultures anaerobically for 24 hours.
  • Exposing cultures to air at low temperatures (6-20°C) for 48 hours to assess activation.
  • Observing and quantifying beta hemolysis against horse, sheep, human, and rabbit red blood cells.

Main Results:

  • Twenty-two (39%) of the pneumococcal strains exhibited beta hemolysis on horse red cells.
  • Six (11%) of the strains showed beta hemolysis on sheep red cells.
  • No lysis of human or rabbit red cells was observed.
  • The hemolytic substance appeared after anaerobic incubation and required subsequent aerobic activation at low temperatures.
  • No correlation was found between serological type and beta hemolysis production.

Conclusions:

  • A novel beta hemolysin produced by certain pneumococcal strains has been identified.
  • This hemolysin specifically targets horse and sheep red blood cells.
  • The activation of this substance is dependent on specific anaerobic and aerobic environmental conditions.
  • The identified hemolysin appears to be distinct from previously described pneumococcal hemolysins.

Related Concept Videos